Table 2.
Relationships between VAT and severity outcomes
| VAT(cm2) | < 90 | 90–120 | 120–150 | 150–180 | > 180 | p value |
|---|---|---|---|---|---|---|
| Number of patients | 7 | 97 | 103 | 69 | 30 | |
| ICU transfer | 0 (0%) | 2 (2.1%) | 5 (4.9%) | 27 (39.1%) | 24 (80.0%) | < 0.001 |
| SAP | 0 (0%) | 0 (0%) | 4 (3.9%) | 13 (18.8%) | 29 (96.7%) | < 0.001 |
| Mortality | 0 (0%) | 0 (0%) | 4 (3.9%) | 8 (11.6%) | 15 (50%) | < 0.001 |
| Systemic complications | 0 (0%) | 3 (3.1%) | 10 (9.7%) | 40 (58.0%) | 29 (96.7%) | < 0.001 |
| Local complications | ||||||
| APFC | 2 (28.6%) | 38 (39.2%) | 28 (27.2%) | 26 (37.7%) | 16 (53.3%) | 0.107 |
| ANC | 0 (0%) | 0 (0%) | 0 (0%) | 8 (11.6%) | 3 (10.0%) | < 0.001 |
| WON | 0 (0%) | 1 (1.0%) | 5 (4.9%) | 6 (8.7%) | 4 (13.3%) | 0.038 |
| Pancreatic pseudocyst | 0 (0%) | 2 (2.1%) | 6 (5.8%) | 8 (11.6%) | 3 (10.0%) | 0.088 |
| Prognostic scores | ||||||
| APACHE-II score ≥ 8 | 0 (0%) | 7 (7.2%) | 8 (7.8%) | 17 (24.6%) | 21 (70.0%) | < 0.001 |
| Ranson’s score ≥ 3 | 0 (0%) | 7 (7.2%) | 6 (5.8%) | 9 (13.0%) | 14 (46.7%) | < 0.001 |
| BISAP score ≥ 3 | 0 (0%) | 2 (2.1%) | 3 (2.9%) | 4 (5.8%) | 5 (16.7%) | 0.048 |
| SIRS score ≥ 2 | 1 (14.3%) | 12 (12.4%) | 22 (21.4%) | 40 (58.0%) | 21 (70.0%) | < 0.001 |
VAT, Visceral adipose tissue; ICU, Intensive care unit; SAP, Severe acute pancreatitis; APFC, Acute peripancreatic fluid collection; ANC, Acute necrotic collection; WON, Walled-off necrosis; APACHE-II, Acute Physiology and Chronic Health Evaluation II; BISAP, Bedside Index of Severity in Acute Pancreatitis; SIRS, systemic inflammatory response syndrome